In this study, we found that the levels of IFN-γ/IL-10 protein in the brain tissue and serum of the amyloid precursor protein/presenilin1 (APP/PS1) and 3xTg (APP/PS1/tau)-AD transgenic mice were significantly increased after treated the lymph nodes with PBMT for one month. This evidence concerns the gene IFNG and Alzheimer disease.